The company ‘Deevona’ has announced that, it is going to launch the company’s innovative Pay-Per-Dose unit dose pharmacy automation service to the market of the United Kingdom for the very first time. Deevona had been the very first company for bringing a fully automated and closed-loop solution for the management if the medication and medical supplies to the United Kingdom followed by a large and successful pilot at the University Hospitals Leicester.
This service has been newly designed the Pay-Per-Dose solution and it is initially offered in the forthcoming months in 2022 for the metropolitan area of London to both the private hospitals and the NHS England and the company is thus opening the market reach to the easy to adopt and short-term contractual arrangements and flexibility in the Pharmacy Automation market of the England.
Gasper G. De Viedma, vice chairman of the board of directors at Deenova said, he has been very bullish regarding this new and exciting new venture particularly on the heels of their 15-year award from the University Hospitals of Leicester NHS Trust in the second largest GDP healthcare market across the continent of Europe.
He also said that, the patient safety and economic advantages of the unique closed-loop medication unit dose system of Deenova had already been clearly evidenced by the positive evaluation. The company is officially going to launch its pay-per-dose unit dose pharmacy automation solution during the Clinical Pharmacy Congress of the United Kingdom.
